S'abonner

Dynamic Amygdala Nuclei Alterations in Relation to Weight Status in Anorexia Nervosa Are Mediated by Leptin - 29/05/24

Doi : 10.1016/j.jaac.2023.08.015 
Marie-Louis Wronski, CandMed a, b, Fabio Bernardoni, PhD a, Klaas Bahnsen, CandMed a, Maria Seidel, PhD a, Dominic Arold, MSc a, Arne Doose, MSc a, Jonas L. Steinhäuser, CandMed a, Katrin Borucki, MD c, Lauren Breithaupt, PhD b, Elizabeth A. Lawson, MD b, Laura M. Holsen, PhD d, Kerstin Weidner, MD e, Veit Roessner, MD e, Joseph A. King, PhD a, Franziska Plessow, PhD b, Stefan Ehrlich, MD, PhD a, e,
a Translational Developmental Neuroscience Section, TU Dresden, Dresden, Germany 
b Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 
c Otto-von-Guericke University Magdeburg, Magdeburg, Germany 
d Division of Women’s Health, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 
e University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany 

Correspondence to Stefan Ehrlich, MD, PhD, Fetscherstraße 74, Dresden 01307, GermanyFetscherstraße 74Dresden01307Germany

Abstract

Objective

The amygdaloid complex is a subcortical limbic group of distinct nuclei. In a previous patient-control study, differential amygdala nuclei alterations were found in acute anorexia nervosa (AN); rostral-medial nuclei involved in fear and reward processing were substantially reduced in volume and associated with hypoleptinemia, a key neuroendocrine characteristic of AN. Here, longitudinal amygdala nuclei alterations in AN were investigated in relation to weight status and their associations with leptin levels.

Method

T1-weighted structural magnetic resonance imaging scans were longitudinally processed with FreeSurfer. Amygdala nuclei volumes in young female patients with acute AN before and after short-term weight restoration (n = 110, >14% body mass index increase over 3 months) and female participants with a history of AN (n = 79, long-term [mean 5 years] weight recovered) were compared with female healthy control participants (n = 271) using linear mixed effects models.

Results

Rostral-medially clustered amygdala nuclei volumes, accessory basal, cortical, medial nuclei, and corticoamygdaloid transition, increased during short-term weight restoration (Cohen's d range 0.18-0.30). However, volumetric normalization across nuclei was heterogeneous. Right cortical, medial nuclei, bilateral corticoamygdaloid transitions, and anterior amygdaloid areas were only partially normalized following short-term weight restoration. Right anterior amygdaloid area remained reduced after long-term weight recovery compared with control participants (d = 0.36). Leptin increase, accompanying short-term weight restoration, mediated the effect of weight gain on volumetric increase in left corticoamygdaloid transition and bilateral medial nuclei.

Conclusion

Rostral-medially clustered amygdala nuclei show pronounced volumetric increase but incomplete normalization in AN during and after short-term weight restoration. Leptin increase may be relevant for the recovery of specific amygdala nuclei in addition to nutritional rehabilitation, indicating links between amygdala substructure and leptin dynamics of potential pathophysiological and clinical relevance in AN.

Plain language summary

The amygdala plays a critical role in processing fearful and rewarding stimuli, and alterations in the amygdala are associated with anorexia nervosa. In this study, the authors measured amygdala nuclei volumes in female patients with acute anorexia nervosa undergoing weight-restoration treatment (n = 110), long-term weight-recovered individuals with anorexia (n = 79), and healthy control participants (n = 271). Structural magnetic resonance imaging revealed that volumes of specific nuclei, clustered in the rostral-medial amygdala, were substantially reduced in acute anorexia nervosa and only partially normalized following weight restoration treatment. Residual reductions in volume persisted even after long-term weight-recovery, compared to healthy control participants. Short-term weight restoration was associated with increases in the neurohormone leptin, and increasing leptin levels were found to mediate the positive impact of weight gain on increased amygdala volume over the treatment course.

Diversity & Inclusion Statement

We worked to ensure race, ethnic, and/or other types of diversity in the recruitment of human participants. We worked to ensure that the study questionnaires were prepared in an inclusive way. One or more of the authors of this paper received support from a program designed to increase minority representation in science. We actively worked to promote sex and gender balance in our author group. We actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our author group. While citing references scientifically relevant for this work, we also actively worked to promote sex and gender balance in our reference list. While citing references scientifically relevant for this work, we also actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our reference list. The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : amygdala nuclei, anorexia nervosa, leptin, longitudinal FreeSurfer subcortical subsegmentation, short-term and long-term weight restoration


Plan


 This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG]: DFG collaborative research center grant SFB 940/2, DFG research grant “Hormonal modulation of neural networks in anorexia nervosa” EH 367/5-1 [PI Stefan Ehrlich], DFG research grant “Dynamic changes in the structural and functional brain connectome in patients with anorexia nervosa” EH 367/7-1 [PI Stefan Ehrlich]), the Swiss Anorexia Nervosa Foundation, and the B. Braun Foundation. Marie-Louis Wronski was supported by a scholarship within the Carus Promotionskolleg Dresden (CPKD) program (structured doctoral program funded by the Else Kröner-Fresenius-Stiftung).
 The research was performed with permission from the TU Dresden Institutional Review Board.
 Consent has been provided for descriptions of specific patient information.
 Jonathan Boss, MSc, of the University of Michigan, served as the statistical expert for this research.
 Author Contributions
Marie-Louis Wronski: Conceptualization, Methodology, Investigation, Data curation, Formal analysis, Software, Visualization, Writing – original draft. Fabio Bernardoni: Conceptualization, Methodology, Software, Data curation, Writing – review & editing, Supervision. Klaas Bahnsen: Methodology, Investigation, Software, Data curation, Writing – review & editing. Maria Seidel: Methodology, Data curation, Writing – review & editing, Supervision. Dominic Arold: Investigation, Software, Data curation, Writing – review & editing. Arne Doose: Investigation, Software, Data curation, Writing – review & editing. Jonas L. Steinhäuser: Investigation, Data curation, Writing – review & editing. Katrin Borucki: Methodology, Resources, Writing – review & editing. Lauren Breithaupt: Methodology, Writing – review & editing. Elizabeth A. Lawson: Methodology, Writing – review & editing. Laura M. Holsen: Methodology, Writing – review & editing. Kerstin Weidner: Resources, Funding acquisition, Writing – review & editing. Veit Roessner: Resources, Funding acquisition, Writing – review & editing. Joseph A. King: Conceptualization, Methodology, Data curation, Writing – review & editing, Supervision. Franziska Plessow: Methodology, Writing – review & editing, Supervision. Stefan Ehrlich: Conceptualization, Methodology, Validation, Resources, Funding acquisition, Writing – review & editing, Supervision, Project administration.
 The authors would like to thank Philipp Sämann, MD, of Max Planck Institute of Psychiatry, Munich, Germany, and the ENIGMA Major Depressive Disorder working group (enigma-hippocampal-subfields/) as well as Emily K. Clarke-Rubright, MSc, of the Brain Imaging and Analysis Center at Duke University, Durham, North Carolina, for advice on substructure quality control (QC) procedures and providing visual QC scripts. The authors would like to thank Jonathan Boss, MSc, of the School of Public Health, University of Michigan, Ann Arbor, Michigan, for support with multiple imputation and providing the censored likelihood multiple imputation R script. The authors thank the Center for Information Services and High Performance Computing (ZIH) at TU Dresden for generous allocations of computing time. The authors express their gratitude to all junior researchers and student research assistants for their help with participant recruitment and data collection and to all study participants for their cooperation.
 Disclosure: Dr. Breithaupt has served as a consultant with Otsuka Pharmaceutical. Dr. Lawson has served on the scientific advisory board and has a financial interest in OXT Therapeutics and has received funding from Tonix Pharmaceuticals for an investigator-initiated study. These interests have been reviewed and are managed by Mass General Brigham. Dr. Roessner has received payment for consulting and writing activities from Eli Lilly, Novartis, and Shire/Takeda Pharmaceuticals; lecture honoraria from Eli Lilly, Novartis, Shire/Takeda Pharmaceuticals, and Medice; and support for research from Novartis and Shire/Takeda Pharmaceuticals. Dr. Roessner has carried out (and is currently carrying out) clinical trials in cooperation with Novartis, Shire/Takeda Pharmaceuticals, and Otsuka Pharmaceutical. Dr. Roessner has reported no financial relationship with the organizations that sponsored the research. Drs. Bernardoni, Seidel, Borucki, Holsen, Weidner, King, Plessow, and Ehrlich and Ms. Wronski and Messrs. Bahnsen, Arold, Doose, and Steinhäuser have reported no biomedical financial interests or potential conflicts of interest.


© 2023  American Academy of Child and Adolescent Psychiatry. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 63 - N° 6

P. 624-639 - juin 2024 Retour au numéro
Article précédent Article précédent
  • Exploring Demographic and Clinical Characteristics of Racially and Ethnically Diverse Youth With Eating Disorders Using California Medicaid Claims Data
  • Erin C. Accurso, Kate Duggento Cordell, Joseph Guydish, Lonnie R. Snowden
| Article suivant Article suivant
  • Independent Prediction of Child Psychiatric Symptoms by Maternal Mental Health and Child Polygenic Risk Scores
  • Lawrence M. Chen, Irina Pokhvisneva, Marius Lahti-Pulkkinen, Tuomas Kvist, Jessie R. Baldwin, Carine Parent, Patricia P. Silveira, Jari Lahti, Katri Räikkönen, Vivette Glover, Thomas G. O’Connor, Michael J. Meaney, Kieran J. O’Donnell

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.